## Cimetidine - Metformin DDI

**Boehringer 2018** Boehringer Ingelheim Pharma GmbH & Co KG. The effect of potent inhibitors of drug
transporters (verapamil, rifampin, cimetidine, probenecid) on pharmacokinetics of a transporter probe drug cocktail consisting of digoxin, furosemide, metformin and rosuvastatin. 2018. BI
Trial No. 0352-2100. EudraCT 2017-001549-29

**Hanke 2020** Hanke N, Türk D, Selzer D, Ishiguro N, Ebner T, Wiebe S, Müller F, Stopfer P, Nock V, Lehr T. A Comprehensive Whole-Body Physiologically Based Pharmacokinetic Drug-Drug-Gene Interaction Model of Metformin and Cimetidine in Healthy Adults and Renally Impaired Individuals. Clin Pharmacokinet. 2020 Nov;59(11):1419-1431. doi: 10.1007/s40262-020-00896-w.

**Somogyi 1987** Somogyi A, Stockley C, Keal J, Rolan P, Bochner F. Reduction of metformin renal tubular secretion by cimetidine in man. Br J Clin Pharmacol. 1987 May;23(5):545-51. doi: 10.1111/j.1365-2125.1987.tb03090.x.

**Wang 2008** Wang ZJ, Yin OQ, Tomlinson B, Chow MS. OCT2 polymorphisms and in-vivo renal functional consequence: studies with metformin and cimetidine. Pharmacogenet Genomics. 2008 Jul;18(7):637-45. doi: 10.1097/FPC.0b013e328302cd41. 


